27 Mar 2015 --- Kappa Bioscience AS, Oslo, Norway, is pleased to announce that following its successful launch in the Australian market, it has appointed ALS Pharmaceutical as the preferred QC laboratory. ALS Pharmaceutical has received Kappa’s full analytical package on vitamin K2 MK-7 and has successfully implemented the technology.
